Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM). (Q40516605)
Jump to navigation
Jump to search
scientific article published on December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM). |
scientific article published on December 2004 |
Statements
1 reference
Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM). (English)
1 reference
Carmen Balaña
1 reference
Antonio López-Pousa
1 reference
Alfonso Berrocal
1 reference
Ricardo Yaya-Tur
1 reference
Ana Herrero
1 reference
Jose-Luis García
1 reference
Javier Martín-Broto
1 reference
Manuel Benavides
1 reference
Miguel Cerdá-Nicolás
1 reference
Rosa Ballester
1 reference
Josep Balart
1 reference
Jaume Capellades
1 reference
1 December 2004
1 reference
1 reference
70
1 reference
3
1 reference
359-369
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference